… New research findings show most doctors are prescribing levodopa … slowing the disease process and they should start taking it early in their disease course. The brain turns levodopa into the neurotransmitter dopamine, which is lost in …

… Johanna Thunell, PhD, is a research scientist at the Leonard D. Schaeffer Center for … an emphasis on both formal and informal caregiving. As an early career investigator, her work has examined methods for … impact of the Medicare Annual Wellness Visit on dementia diagnosis rates, and highlighted racial and ethnic …

… behavior disorder (iRBD) are at high risk for a clinical diagnosis of an α-synucleinopathy (aSN). They could serve as … imaging is a strong candidate biomarker for risk of aSN diagnosis in iRBD. Our primary objective was to identify a … iRBD. Methods:  The sample included individuals with iRBD, early Parkinson's Disease (PD), and healthy controls (HC) …

… diagnostic tool that could be used to detect Parkinson's early in the disease course. Study Design: We will examine … are consistent across all sample time points. Impact on Diagnosis/Treatment of Parkinson's Disease: A non-invasive marker of Parkinson's early in the disease course could allow for early diagnosis …

… Study Rationale:  Although diagnosis of Parkinson’s disease (PD) is crucial for the success of treatment, especially in the early stages, there are still no biomarkers available for … distinguishing it from other neurological disorders in the early stages of disease is important for treatment, which …

… common in Parkinson’s disease (PD) and often occur prior to diagnosis. For the study, researchers surveyed more than 47,000 people about their … – such as environment or lifestyle – that play a role. Or early, undetected symptoms could lead people to change to a …